Table 2.
Distribution of HCC etiology by race/ethnicity and sex for 2,594 FCDS-AHCA matched cases in Florida, 2014–2015.
| Level I Race-Ethnicity |
Level II Race-Ethnicity |
Total N† | HCV | HBV | ALD | Metabolic‡ | Cryptogenic | |
|---|---|---|---|---|---|---|---|---|
| MALE | ||||||||
| White | 1,285 | 49.7% | 2.6% | 16.0% | 26.9% | 4.0% | ||
| Black § | 250 | 60.0% | 12.4% | 12.0% | 12.0% | - | ||
| African American | 220 | 64.1% | 8.2% | 11.8% | 11.8% | - | ||
| Afro-Caribbean | 27 | - | 48.1% | - | - | - | ||
| API | 38 | 34.2% | 26.3% | - | - | - | ||
| Hispanic § | 360 | 44.0% | 3.6% | 18.6% | 28.1% | 4.4% | ||
| Puerto Rican | 123 | 60.2% | - | 18.7% | 14.6% | - | ||
| Cuban | 112 | 43.8% | - | 8.9% | 39.3% | - | ||
| Continental Hispanic | 109 | 29.4% | - | 29.4% | 30.3% | - | ||
| All Race-Ethnicities Combined ¶ | 1,956 | 49.6% | 4.4% | 16.2% | 25.1% | 3.9% | ||
| FEMALE | ||||||||
| White | 374 | 43.0% | - | 11.2% | 36.1% | 7.2% | ||
| Black § | 96 | 60.4% | - | - | 24.0% | - | ||
| African American | 82 | 61.0% | - | - | 23.2% | - | ||
| Afro-Caribbean | 12 | - | - | - | - | - | ||
| API | 28 | 42.9% | - | - | - | - | ||
| Hispanic § | 129 | 27.9% | - | - | 54.3% | 9.3% | ||
| Puerto Rican | 36 | 47.2% | - | - | 41.7% | - | ||
| Cuban | 38 | 26.3% | - | - | 57.9% | - | ||
| Continental Hispanic | 47 | <15% | - | - | 66.0% | - | ||
| All Race-Ethnicities Combined ¶ | 638 | 42.8% | 2.2% | 8.9% | 37.1% | 7.4% | ||
†.
Includes all listed as well as Others (biliary, genetic and auto-immune)
‡.
Including NAFLD, obesity, type 2 diabetes, metabolic syndrome
§.
Includes all cases of this race-ethnicity; not just listed groups
¶.
All Race-Ethnicities Combined also includes those not listed here (i.e. multiracial, other, and unknown race)
-
Not reported; observations fewer than 10
API: Asian/Pacific Islander